Home>News & Events>Events>TRxA

News & Events

  • February 8, 2023

    View Now: Webinar – TRxA 2023 Funding Opportunities

    C-Path’s Translational Therapeutics Accelerator is a global drug discovery support program that leverages C-Path’s proficiency in translational and regulatory science to bridge the drug development “valley of death.” TRxA accomplishes this by providing academic researchers with funding and guidance to define optimal strategies to advance cutting-edge new therapeutics from the lab to clinical trials and, ultimately, patient care.

  • February 6, 2023

    View Now: Critical Path to Women Leading in Science

     Date: Feb 6, 2022 | 1:30 PM Eastern Time (US and Canada) Please join C-Path for a 90-minute roundtable discussing the Critical Path Institute’s programs and consortia, highlighted by various women leaders at this public-private partnership. The team will discuss how C-Path contributes to transforming and accelerating the medical product development process, as well as......
Refine:

Period

Program

  • All Programs
  • TTC - Transplant Therapeutics Consortium
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • TRxA - Translational Therapeutics Accelerator
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • PredicTox KE - PredicTox Knowledge Environment
  • CP-SCD - Critical Path for Sickle Cell Disease
  • CDRC - CURE Drug Repurposing Collaboratory
  • QuantMed - Quantitative Medicine Program
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • T1D - Type 1 Diabetes Consortium
  • CPAD - Critical Path for Alzheimer's Disease
  • BmDR - Biomarker Data Repository
  • CFAST - Coalition For Accelerating Standards and Therapies
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x